AstraZeneca and 4D Molecular Therapeutics explore gene therapy for lung disease 13-Jul-2018 By Ben Hargreaves AstraZeneca and 4D Molecular Therapeutics have formed a collaboration to develop a gene therapy for patients with chronic lung disease.